Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gathoni Kamuyu

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Human Vaccines & Immunotherapeutics|September 18, 2025
Future directions in combating outbreaks at CEPI Centralized Laboratory NetworkAli Azizi, Gathoni Kamuyu, Peter Spencer, et al.
Immunology|June 25, 2017
Vaccine candidate discovery for the next generation of malaria vaccinesJames Tuju, Gathoni Kamuyu, Linda M Murungi, et al.
Nature Medicine|January 3, 2025
Preparedness and priority research to tackle the mpox outbreak responseAli Azizi, Kristine Rose, Gathoni Kamuyu, et al.
Journal of Immunological Methods|May 15, 2025
Chlamydia trachomatis pgp3 ELISAFilomeno Coelho da Silva, Gathoni Kamuyu, Kazutomo Yokoya, et al.
Frontiers in Immunology|July 1, 2026
Development and validation of a pseudotyped virus neutralization assay for quantification of anti-Lassa virus neutralizing antibodiesEdward T Mee, Emma M Bentley, Gathoni Kamuyu, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2019
Serological Profiling for Malaria Surveillance Using a Standard ELISA ProtocolLinda M Murungi, Rinter K Kimathi, James Tuju, et al.
NPJ Vaccines|July 16, 2024
Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory NetworkAli Azizi, Deborah Ogbeni, Gathoni Kamuyu, et al.
Vaccine|June 27, 2013
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malariaLinda M Murungi, Gathoni Kamuyu, Brett Lowe, et al.
The Journal of Infectious Diseases|February 4, 2026
Influence of Chlamydia trachomatis sequence variation on Pgp3 antigenicityFilomeno Coelho da Silva, Kazutomo Yokoya, Rana Hussain, et al.
Journal of Immunological Methods|September 26, 2024
Candidate antibody reference reagents for Chlamydia trachomatis serologyFilomeno Coelho da Silva, Gathoni Kamuyu, Birgitta Michels, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|September 18, 2025
Future directions in combating outbreaks at CEPI Centralized Laboratory NetworkAli Azizi, Gathoni Kamuyu, Peter Spencer, et al.
Immunology|June 25, 2017
Vaccine candidate discovery for the next generation of malaria vaccinesJames Tuju, Gathoni Kamuyu, Linda M Murungi, et al.
Nature Medicine|January 3, 2025
Preparedness and priority research to tackle the mpox outbreak responseAli Azizi, Kristine Rose, Gathoni Kamuyu, et al.
Journal of Immunological Methods|May 15, 2025
Chlamydia trachomatis pgp3 ELISAFilomeno Coelho da Silva, Gathoni Kamuyu, Kazutomo Yokoya, et al.
Frontiers in Immunology|July 1, 2026
Development and validation of a pseudotyped virus neutralization assay for quantification of anti-Lassa virus neutralizing antibodiesEdward T Mee, Emma M Bentley, Gathoni Kamuyu, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2019
Serological Profiling for Malaria Surveillance Using a Standard ELISA ProtocolLinda M Murungi, Rinter K Kimathi, James Tuju, et al.
NPJ Vaccines|July 16, 2024
Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory NetworkAli Azizi, Deborah Ogbeni, Gathoni Kamuyu, et al.
Vaccine|June 27, 2013
A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malariaLinda M Murungi, Gathoni Kamuyu, Brett Lowe, et al.
The Journal of Infectious Diseases|February 4, 2026
Influence of Chlamydia trachomatis sequence variation on Pgp3 antigenicityFilomeno Coelho da Silva, Kazutomo Yokoya, Rana Hussain, et al.
Journal of Immunological Methods|September 26, 2024
Candidate antibody reference reagents for Chlamydia trachomatis serologyFilomeno Coelho da Silva, Gathoni Kamuyu, Birgitta Michels, et al.
Pageof 4